Alka-Seltzer Plus Severe Cold Night PowerFast Fizz 325 mg/1
aspirin, doxylamine succinate, dextromethorphan hydrobromide, phenylephrine bitartrate · TABLET, EFFERVESCENT · Bayer HealthCare LLC.
Alka-Seltzer Plus Severe Cold Night Powerfast Fizz is an over-the-counter medication that combines a pain reliever, decongestant, cough suppressant, and antihistamine to relieve multiple cold and flu symptoms. The effervescent tablet dissolves in water and is designed to provide relief, particularly for nighttime use when symptoms may interfere with sleep.
Key Facts
- Brand Name
- Alka-Seltzer Plus Severe Cold Night PowerFast Fizz
- Generic Name
- aspirin, doxylamine succinate, dextromethorphan hydrobromide, phenylephrine bitartrate
- NDC Code (Product)
0280-0068- Manufacturer
- Bayer HealthCare LLC.
- Strength
- 325 mg/1
- Dosage Form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Marketing Status
- HUMAN OTC DRUG
- Application #
- M012
- Drug Class
- Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents
- Marketing Start
- 07/12/2021
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses temporarily relieves these symptoms due to a cold: minor aches and pains headache runny nose sinus congestion and pressure cough sneezing sore throat nasal congestion temporarily reduces fever
Dosage & Administration
Directions ● adults and children 12 years and over: take 2 tablets fully dissolved in 4 oz of water every 4 hours. Do not exceed 8 tablets in 24 hours or as directed by a doctor. ● children under 12 years of age: do not use
Warnings
Warnings Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Allergy alert: Aspirin may cause a severe allergic reaction which may include: hives facial swelling asthma (wheezing) shock Stomach bleeding warning : This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you are age 60 or older have had stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Sore throat warning : If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea,or vomiting, consult a doctor promptly. Do not use to sedate children. Do not use if you are allergic to aspirin or any other pain rel…
Frequently Asked Questions
What is Alka-Seltzer Plus Severe Cold Night PowerFast Fizz used for?
Alka-Seltzer Plus Severe Cold Night Powerfast Fizz is an over-the-counter medication that combines a pain reliever, decongestant, cough suppressant, and antihistamine to relieve multiple cold and flu symptoms. The effervescent tablet dissolves in water and is designed to provide relief, particularly for nighttime use when symptoms may interfere with sleep.
Is Alka-Seltzer Plus Severe Cold Night PowerFast Fizz a controlled substance?
Alka-Seltzer Plus Severe Cold Night PowerFast Fizz is not classified as a controlled substance by the DEA.
What is the generic name for Alka-Seltzer Plus Severe Cold Night PowerFast Fizz?
The generic name for Alka-Seltzer Plus Severe Cold Night PowerFast Fizz is aspirin, doxylamine succinate, dextromethorphan hydrobromide, phenylephrine bitartrate. There are no other listed brand versions of aspirin, doxylamine succinate, dextromethorphan hydrobromide, phenylephrine bitartrate.
What is the NDC code for Alka-Seltzer Plus Severe Cold Night PowerFast Fizz 325 mg/1?
The NDC (National Drug Code) for Alka-Seltzer Plus Severe Cold Night PowerFast Fizz 325 mg/1 is 0280-0068, listed by Bayer HealthCare LLC..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)